Lamb, CA
38  results:
Search for persons X
?
1

Neutralising antibody potency against SARS-CoV-2 wild-type ..:

Liu, Z ; Le, K ; Zhou, X...
https://openaccess.sgul.ac.uk/id/eprint/115739/1/1-s2.0-S2468125322003892-main.pdf.  , 2023
 
?
4

Opioid use and associated factors in 1676 patients with inf..:

Baillie, S ; Limdi, JK ; Bassi, A...
https://openaccess.sgul.ac.uk/id/eprint/115580/1/Opioid%20exposure%20and%20associated%20factors%20QIP_FL_Response_May23_tracked%20changes%20removed_tables.docx.  , 2023
 
?
5

Withdrawal of infliximab or concomitant immunosuppressant t..:

Louis, E ; Resche-Rigon, M ; Laharie, D...
https://openaccess.sgul.ac.uk/id/eprint/115531/1/1-s2.0-S2468125322003855-main.pdf.  , 2023
 
?
8

Vaccine escape, increased breakthrough and reinfection in i..:

Kennedy, NA ; Janjua, M ; Chanchlani, N...
https://openaccess.sgul.ac.uk/id/eprint/114625/1/CLARITY%203rd%20dose%20paper%20-%20clean%20revision%20with%20figures.docx.  , 2022
 
?
10

Using faecal immunochemical test (FIT) undertaken in a nati..:

Masi, AC ; Koo, S ; Lamb, CA...
https://eprints.whiterose.ac.uk/167496/8/GUT%20microbiome%20letter%20AAM.pdf.  , 2021
 
?
12

Inflammatory bowel disease clinical service recovery during..:

Din, S ; Gaya, D ; Kammermeier, J...
https://openaccess.sgul.ac.uk/id/eprint/113955/1/77.full.pdf.  , 2021
 
?
13

Infliximab is associated with attenuated immunogenicity to ..:

Kennedy, NA ; Lin, S ; Goodhand, JR...
https://openaccess.sgul.ac.uk/id/eprint/113201/1/CLARITY%20vaccine%20revision%20clean%20-%20manuscript.docx.  , 2021
 
?
14

Assessment, endoscopy, and treatment in patients with acute..:

Sebastian, S ; Walker, GJ ; Kennedy, NA...
https://discovery.ucl.ac.uk/id/eprint/10123007/7/Sebepos-Rogers_main.pdf.  , 2021
 
?
15

Anti-SARS-CoV-2 antibody responses are attenuated in patien..:

Kennedy, NA ; Goodhand, JR ; Bewshea, C...
https://openaccess.sgul.ac.uk/id/eprint/113076/1/R1%20CLARITY%20II%20manuscript%20Gut.docx.  , 2021
 
1-15